Streetbeat News

Analyst Ratings

BDC

Goldman Sachs analyst Mark Delaney has maintained a 'Buy' rating on Belden (NYSE:BDC) but lowered the price target from $106 to $91.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:22 pm

DFH

Wedbush analyst Jay McCanless has maintained a Neutral rating on Dream Finders Homes (NYSE:DFH) and raised the price target from $16 to $19.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:21 pm

AUR

Goldman Sachs analyst Mark Delaney has maintained a Neutral rating on Aurora Innovation (NASDAQ:AUR) and lowered the price target from $2.5 to $1.75.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:20 pm

BROS

Wedbush analyst Nick Setyan has maintained an Outperform rating on Dutch Bros (NYSE:BROS), but lowered the price target from $37 to $31.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:19 pm

APPN

Goldman Sachs analyst Kevin Kumar has maintained a 'Buy' rating on Appian (NASDAQ:APPN) but lowered the price target from $58 to $50.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:19 pm

PCT

Bleecker Street Research has issued a report titled 'PureCycle's (PCT) Failure To Launch', which may have implications for PureCycle Technologies' stock performance.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:18 pm

AGIO

Goldman Sachs analyst Salveen Richter maintains a Neutral rating on Agios Pharmaceuticals (NASDAQ:AGIO) and lowers the price target from $32 to $28.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:18 pm

AAPL

BA

SPGI

On CNBC's 'Halftime Report Final Trades', Josh Brown of Ritholtz Wealth Management recommended Apple Inc., which recently reported stronger-than-expected earnings and sales for Q4, despite iPhone revenue falling slightly short of expectations. Jim Lebenthal of Cerity Partners recommended Boeing Co, which is recovering despite a recent cyberattack on its global services division. Karen Firestone of Aureus Asset Management recommended S&P Global Inc, which reported better-than-expected Q3 results and raised its annual profit outlook.

Portfolio Pulse from Lisa Levin

November 03, 2023 | 2:18 pm

CHUY

Wedbush analyst Nick Setyan has maintained an 'Outperform' rating on Chuy's Holdings (NASDAQ:CHUY) but lowered the price target from $42 to $41.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:18 pm

MRNA

Moderna's stock has been upgraded from Reduce to Hold by HSBC, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

November 03, 2023 | 2:17 pm